180 Life Sciences Stock Jumps on $156 Million Notes Sale

Dow Jones
2025/08/12

By Dean Seal

 

Shares of 180 Life Sciences climbed after the company sold $156 million in convertible notes in order to load up its ether reserves.

The stock was up 11% at $3.32 in afternoon trading. Shares have now gained 83% since the start of the year.

The dietary supplement and food ingredient company said before the opening bell that it has sold $156 million worth of senior secured convertible notes due 2028 in a private offering.

The notes have a conversion price of $3.445 a share, subject to a one-time downward reset on the nine-month anniversary of the notes issuance if the closing price on that date is less than the conversion price.

Proceeds will be used to buy more ether for the company's ethereum treasury strategy.

 

Write to Dean Seal at dean.seal@wsj.com

 

(END) Dow Jones Newswires

August 11, 2025 13:34 ET (17:34 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10